Allergan Sales, 5% 15dec2021, USD (FIGI RegS BBG005P207H2, WKN A1ZL7C)
国際債券, Senior Unsecured
国際債券, Senior Unsecured
|
Allergan Sales, LLC (f.n.a.Forest Laboratories, Inc. (Forest)) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. The Company focuses on the development and introduction of new products, including products developed ...
Allergan Sales, LLC (f.n.a.Forest Laboratories, Inc. (Forest)) develops, manufactures and sells branded forms of ethical drug products, which requires a physician's prescription. The Company focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. The Company’s products include Namenda, the Company's NMDA antagonist for the treatment of moderate to severe dementia of the Alzheimer's type; Bystolic is a beta-blocker for the treatment of hypertension; Linzess is a guanylate cyclase type-C receptor agonist for the once-daily treatment for men and women suffering from IBS-C or CIC; Tudorza is a long-acting antimuscarinic agent for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and Viibryd is an SSRI and a 5-HT1A receptor partial agonist for the treatment of adults with major depressive disorder (MDD).
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡